Eyenovia Announces Conference Call and Webcast for Third Quarter 2019 Financial Results

Date : 10/31/2019 @ 12:30PM
Source : GlobeNewswire Inc.
Stock : Eyenovia Inc (EYEN)
Quote : 4.79  -0.13 (-2.64%) @ 7:50PM
Eyenovia share price Chart

Eyenovia Announces Conference Call and Webcast for Third Quarter 2019 Financial Results

Eyenovia (NASDAQ:EYEN)
Historical Stock Chart

3 Months : From Oct 2019 to Jan 2020

Click Here for more Eyenovia Charts.

Eyenovia, Inc. (NASDAQ: EYEN), a clinical stage ophthalmic biopharmaceutical company developing a pipeline of microdose therapeutics utilizing its patented piezo-print delivery technology, today announced that the Company will release financial results for the third quarter ended September 30, 2019 on Wednesday, November 13, 2019, after the market closes. Following the release, Dr. Sean Ianchulev, Chief Executive Officer and Chief Medical Officer, John Gandolfo, Chief Financial Officer, and Michael Rowe, Vice President, Commercial will host a conference call to review the financial results.

The conference call is scheduled to begin at 5:00 pm ET on Wednesday, November 13, 2019. Participants should dial 1-866-916-2921 (United States) or 1-210-874-7771 (International) with the conference code 6128678. A live webcast of the conference call will also be available on the investor relations page of the Company's corporate website at www.eyenovia.com.

After the live webcast, the event will be archived on Eyenovia’s website for one year. In addition, a telephonic replay of the call will be available until November 20, 2019. The replay can be accessed by dialing 1-855-859-2056 (United States) or 1-404-537-3406 (International) with confirmation code 6128678.

About EyenoviaEyenovia, Inc. (NASDAQ: EYEN) is a clinical stage ophthalmic biopharmaceutical company developing a pipeline of microdose therapeutics utilizing its patented piezo-print delivery technology. Eyenovia’s pipeline is currently focused on the late-stage development of microdosed medications for presbyopia, myopia progression and mydriasis. For more Information please visit www.eyenovia.com.

Company Contact:Eyenovia, Inc.John GandolfoChief Financial Officerjgandolfo@eyenoviabio.com 

Investor Contact:The Ruth GroupTram Bui / Alexander LoboPhone: 646-536-7035/7037tbui@theruthgroup.com / alobo@theruthgroup.com 

Media Contact:The Ruth GroupKirsten ThomasPhone: 508-280-6592kthomas@theruthgroup.com 

Latest EYEN Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:us D:20200117 20:08:04